Table 2.
Baseline characteristics comparing hypermobile and non-hypermobile patients as well as symptomatic and asymptomatic patients
| Parameter | Mobility status | Symptom status | ||||
|---|---|---|---|---|---|---|
| Hypermobile | Non-hypermobile | Symptomatic | Asymptomatic | |||
| (N = 24) | (N = 8) | P value | (N = 29) | (N = 3) | P value | |
| Age, years, mean (SD) | 54.5 ± 15.8 | 46.2 ± 16.5 | 0.064 | 51.4 ± 15.9 | 50.3 ± 18.5 | 0.83 |
| Sex, male/female, (%) | 18.2/81.8 | 17.4/82.6 | 1.00 | 14.6/85.4 | 26.7/73.3 | 0.43 |
| BMI (kg/m2) | 22.7 ± 2.8 | 22.7 ± 3.1 | 0.98 | 22.9 ± 2.4 | 22.2 ± 3.9 | 0.47 |
| Beighton score, < 3/≥ 3, (%) | 0.7 ± 1 | 1.7 ± 2.6 | 0.053 | 1.3 ± 2.1 | 0.6 ± 0.98 | 0.43 |
| Length of feet (mm) | 23.3 ± 1.5 | 23.5 ± 1.1 | 0.73 | 23.4 ± 1.4 | 23.4 ± 1.3 | 0.97 |
| Width of feet (mm) | 9.9 ± 0.7 | 9.5 ± 0.7 | 0.037* | 9.8 ± 0.8 | 9.7 ± 0.8 | 0.79 |
| First metatarsal length (mm) | 62.3 ± 4.6 | 63.5 ± 4.9 | 0.35 | 62.4 ± 4.6 | 63.9 ± 5 | 0.31 |
| Second metatarsal length (mm) | 73.1 ± 6 | 74.7 ± 5.5 | 0.33 | 73.2 ± 5.8 | 75.3 ± 5.9 | 0.2 |
| HV angle (degrees) | 32.2 ± 9.8 | 26.9 ± 9.2 | 0.046* | 32.3 ± 8.3 | 23.9 ± 11.2 | 0.004* |
| 1–2 IM angle (degrees) | 14.9 ± 3.4 | 14.9 ± 5.4 | 0.98 | 15.6 ± 4.6 | 12.8 ± 2.5 | 0.028* |
Hypermobility = Positive Klaue device > 9.3 mm translation
*Statistically significant (P < 0.05)